Sherwin-Williams (NYSE:SHW) Price Target Raised to $370.00

Sherwin-Williams (NYSE:SHW) had its price objective hoisted by Barclays from $355.00 to $370.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price target would indicate a potential upside of 2.39% from the company’s current price.

Other equities analysts have also issued reports about the stock. Morgan Stanley upped their price target on shares of Sherwin-Williams from $375.00 to $450.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. StockNews.com upgraded shares of Sherwin-Williams from a “hold” rating to a “buy” rating in a research report on Tuesday. Wells Fargo & Company upped their target price on shares of Sherwin-Williams from $350.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 15th. Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research report on Thursday, July 18th. Finally, Evercore ISI increased their target price on shares of Sherwin-Williams from $365.00 to $380.00 and gave the company an “outperform” rating in a research note on Friday, August 30th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $386.29.

Sherwin-Williams Stock Performance

SHW opened at $361.38 on Wednesday. The firm has a market cap of $91.16 billion, a P/E ratio of 36.84, a PEG ratio of 3.04 and a beta of 1.17. Sherwin-Williams has a 1-year low of $232.06 and a 1-year high of $392.57. The company has a 50 day simple moving average of $371.59 and a two-hundred day simple moving average of $334.45. The company has a debt-to-equity ratio of 2.17, a current ratio of 0.81 and a quick ratio of 0.50.

Sherwin-Williams (NYSE:SHW) last posted its quarterly earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing analysts’ consensus estimates of $3.56 by ($0.19). The firm had revenue of $6.16 billion during the quarter, compared to the consensus estimate of $6.20 billion. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. The business’s revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.20 earnings per share. Equities analysts forecast that Sherwin-Williams will post 11.49 earnings per share for the current fiscal year.

Insider Activity at Sherwin-Williams

In related news, CFO Allen J. Mistysyn sold 14,520 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $366.83, for a total value of $5,326,371.60. Following the completion of the transaction, the chief financial officer now directly owns 63,520 shares of the company’s stock, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Sherwin-Williams

Hedge funds and other institutional investors have recently modified their holdings of the stock. HHM Wealth Advisors LLC raised its position in Sherwin-Williams by 102.3% during the 2nd quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 45 shares during the last quarter. Semmax Financial Advisors Inc. raised its position in Sherwin-Williams by 136.4% during the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock worth $31,000 after buying an additional 60 shares during the last quarter. VitalStone Financial LLC raised its position in Sherwin-Williams by 233.3% during the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 77 shares during the last quarter. Anfield Capital Management LLC purchased a new position in Sherwin-Williams during the 2nd quarter worth approximately $38,000. Finally, Meeder Asset Management Inc. purchased a new position in Sherwin-Williams during the 2nd quarter worth approximately $41,000. 77.67% of the stock is owned by hedge funds and other institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.